Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking

Author:

Schuller MarionORCID,Correy Galen J.ORCID,Gahbauer StefanORCID,Fearon DarenORCID,Wu TaiaseanORCID,Díaz Roberto EfraínORCID,Young Iris D.ORCID,Martins Luan CarvalhoORCID,Smith Dominique H.,Schulze-Gahmen UrsulaORCID,Owens Tristan W.ORCID,Deshpande IshanORCID,Merz Gregory E.ORCID,Thwin Aye C.ORCID,Biel Justin T.ORCID,Peters Jessica K.ORCID,Moritz MichelleORCID,Herrera NadiaORCID,Kratochvil Huong T.ORCID,Aimon AnthonyORCID,Bennett James M.ORCID,Neto Jose BrandaoORCID,Cohen Aina E.ORCID,Dias AlexandreORCID,Douangamath AliceORCID,Dunnett LouiseORCID,Fedorov OlegORCID,Ferla Matteo P.ORCID,Fuchs MartinORCID,Gorrie-Stone Tyler J.ORCID,Holton James M.ORCID,Johnson Michael G.,Krojer TobiasORCID,Meigs George,Powell Ailsa J.ORCID,Rack Johannes Gregor MatthiasORCID,Rangel Victor LORCID,Russi SilviaORCID,Skyner Rachael E.ORCID,Smith Clyde A.ORCID,Soares Alexei S.ORCID,Wierman Jennifer L.ORCID,Zhu KangORCID,Jura NataliaORCID,Ashworth AlanORCID,Irwin JohnORCID,Thompson Michael C.ORCID,Gestwicki Jason E.ORCID,von Delft FrankORCID,Shoichet Brian K.ORCID,Fraser James S.ORCID,Ahel IvanORCID,

Abstract

ABSTRACTThe SARS-CoV-2 macrodomain (Mac1) within the non-structural protein 3 (Nsp3) counteracts host-mediated antiviral ADP-ribosylation signalling. This enzyme is a promising antiviral target because catalytic mutations render viruses non-pathogenic. Here, we report a massive crystallographic screening and computational docking effort, identifying new chemical matter primarily targeting the active site of the macrodomain. Crystallographic screening of diverse fragment libraries resulted in 214 unique macrodomain-binding fragments, out of 2,683 screened. An additional 60 molecules were selected from docking over 20 million fragments, of which 20 were crystallographically confirmed. X-ray data collection to ultra-high resolution and at physiological temperature enabled assessment of the conformational heterogeneity around the active site. Several crystallographic and docking fragment hits were validated for solution binding using three biophysical techniques (DSF, HTRF, ITC). Overall, the 234 fragment structures presented explore a wide range of chemotypes and provide starting points for development of potent SARS-CoV-2 macrodomain inhibitors.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3